Search
Levobunolol
go.drugbank.com/drugs/DB01210ApprovedA nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.
Products: VISTAGAN LIQUIFILM 0.5%O KPropantheline
go.drugbank.com/drugs/DB00782ApprovedA muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
Categories: Drugs for Functional Gastrointestinal DisordersInecalcitol
go.drugbank.com/drugs/DB04796InvestigationalSynonyms: (7E)-19-Nor-9,10-seco-14beta-cholesta-5,7-dien-23-yne-1alpha,3beta,25-triolMatuzumab
go.drugbank.com/drugs/DB05101InvestigationalIt has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
Thalagen
go.drugbank.com/drugs/DB17714ExperimentalIt is being investigated for the treatment of beta-thalassemia.[L46168] … Thalagen is a branded product developed by San Rocco Therapeutics.
Cagrilintide
go.drugbank.com/drugs/DB18887InvestigationalCagrilintide is under investigation in clinical trial NCT06221969 (A Research Study to See How Much Cagrisema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated … With Metformin With or Without an SGLT2 Inhibitor).
Tolperisone
go.drugbank.com/drugs/DB06264InvestigationalIt possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem, spinal cord and peripheral nerves.
Categories: Topical Products for Joint and Muscular PainIva axillaris pollen
go.drugbank.com/drugs/DB10764ApprovedIva axillaris pollen is the pollen of the Iva axillaris plant. Iva axillaris pollen is mainly used in allergenic testing.
Mixtures: Number Four Weed MixtureCergutuzumab amunaleukin
go.drugbank.com/drugs/DB14874InvestigationalCergutuzumab amunaleukin is under investigation in clinical trial NCT02004106 (A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid
2-Methoxyestradiol
go.drugbank.com/drugs/DB02342Investigational2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis).